Flexibility for Your Patients With CIDP

With convenient weekly dosing, patients can fit Hizentra into their normal routine

Self-administration gives you and your CIDP patients the freedom to choose:


Patient routine icon

Your CIDP patient's routine

Infusion timing icon

How long the self-infusions take

Infusion dose icon

How much medicine is given per infusion

Infusion sites icon

How many infusion sites your patients use

Hizentra provides flexibility for a wide range of patient needs

Has venous access issues

Requires more frequent infusions

Seeks flexibility, freedom, and control

Hizentra Patient: Alice Alice 80-year-old female
165 lb (75 kg)

Why Hizentra?

  • She doesn't want to face difficulties of nurses finding a vein, nor does she want a port
  • Infusing at home is helpful, because she has a caregiver who can assist with the infusions
Hizentra venous access issues dosing calendar
Weekly dose: 15 g/75 mL
Rate of infusion: 30 mL/hr/site
Infusion sites: 2
Time per infusion: ~1 hour and 15 minutes
Hizentra Patient: Miguel Miguel 55-year-old male
176 lb (80 kg)

Why Hizentra?

  • Going to the IV clinic more often is a hassle– self-infusion at home would give him the freedom and flexibility he needs
  • More frequent infusions also mean less volume per infusion and he can infuse in about an hour
Hizentra frequent infusion dosing calendar
Weekly dose: 16 g/80 mL (2 sessions over 2 days)
Rate of infusion: 40 mL/hr/site
Infusion sites: 1
Time per infusion: ~1 hour
Hizentra Patient: Allison Allison 40-year-old female
154 lb (70 kg)

Why Hizentra?

  • She needs an infusion regimen that fits her busy work and home-life schedule
  • Self-infusion where and when she chooses lets her continue her day without infusion-appointment interruptions
Hizentra weekly dose calendar
Weekly dose: 14 g/70 mL
Rate of infusion: 45 mL/hr/site
Infusion sites: 2
Time per infusion: ~45 min

Recommended subcutaneous dose is 0.2 g/kg (1 mL/kg) body weight per week. In the clinical study, after transitioning from IVIg to Hizentra, 0.4 g/kg body weight per week was also safe and effective to prevent CIDP relapse.

In the PATH Study
Most CIDP patients reported Hizentra easy to use5

88% of patients reported Hizentra easy to use* pic chart
  • All patients or caregivers learned to effectively administer Hizentra on their own after 4 or fewer training sessions8
*Based on last postdose observation (n=154). Exploratory endpoint, captured with the TSQM (Treatment Satisfaction Questionnaire for Medication, version 1.4) on a 7-point scale, ranging from extremely difficult to extremely easy. This set was dichotomized into “difficult” for the categories extremely difficult, very difficult, and difficult; and into "easy" for the categories somewhat easy, easy, very easy, and extremely easy.

Self-administration gives patients like James the freedom to infuse at a place and time convenient to them

Patient started Hizentra after years of every 28-day IVIg.

Frequently asked questions about Hizentra for CIDP

Want to know more about Hizentra?  We have the answers to prescribers' frequently asked questions.

See the answers

Hizentra dosing and administration for CIDP

Explore helpful tools for and additional information about self-infusing Hizentra.

See dosing options and administration
You are now leaving the current website.

Do you want to continue?

No Yes